CURE
GBLX CURE ETF UNITS [CURE]
About CURE
Global X S&P Biotech ETF (CURE, formerly ETFS S&P Biotech ETF) is an exchange traded fund that provides exposure to U.S. healthcare biotechnology companies. These companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering.
Buy Australian shares starting with CURE. Invest today with a CHESS-sponsored broker!
Market Capitalisation
$41M
Price-earnings ratio
-1.70
Dividend yield
0.06%
High today
$39.88
Low today
$39.20
Open price
$39.60
52-week high
$46.35
52-week low
$31.08
Announcements
CURE FAQs
How much is one share of GBLX CURE ETF UNITS [CURE]?
One share of GBLX CURE ETF UNITS [CURE] is valued at $39.49.
What is the ticker symbol for GBLX CURE ETF UNITS [CURE]?
The ticker symbol for GBLX CURE ETF UNITS [CURE] is CURE.
How do I buy CURE shares in Australia?
To buy CURE stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in CURE
What is the 52-week high for GBLX CURE ETF UNITS [CURE] stock?
The GBLX CURE ETF UNITS [CURE] 52-week high stock price is $46.35.
What is the 52-week low for GBLX CURE ETF UNITS [CURE] stock?
The GBLX CURE ETF UNITS [CURE] 52-week low stock price is $31.08.
What is the market capitalisation of GBLX CURE ETF UNITS [CURE] CURE?
As of 20/03/2023 GBLX CURE ETF UNITS [CURE] has a market cap of $41M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.